Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-29

FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Atenolol by Aurobindo Pharma Limited, granting approval of a generic version under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atenolol (Atenolol)

Snippet

SUPPL AP for ATENOLOL (ATENOLOL)